临床普外科电子杂志 ›› 2025, Vol. 13 ›› Issue (2): 93-.

• • 上一篇    下一篇

头孢曲松联合奥硝唑用于急性化脓性阑尾炎围手术期抗感染治疗效果

  

  1. 1. 桂林市中西医结合医院 药学部,广西 桂林 541000;2. 桂林市中西医结合医院 普外科,广西 桂林 541000
  • 出版日期:2025-04-01 发布日期:2025-08-12

The effect of ceftriaxone combined with metronidazole in the perioperative anti infective treatment of acute suppurative appendicitis

  1. 1. Pharmacy Department of Guilin Integrated Traditional Chinese and Western Medicine Hospital, Guangxi Guilin 541000, China;  2. General Surgery Department of Guilin Integrated Traditional Chinese and Western Medicine Hospital, Guilin Guangxi 541000, China
  • Online:2025-04-01 Published:2025-08-12

摘要:

目的 观察对急性化脓性阑尾炎围手术期患者使用头孢曲松联合奥硝唑抗感染治疗的效果。方法 回顾分析 2023 年 5 月至 2024 年 5 月桂林市中西医结合医院 80 例常规术后抗感染(氨曲南 + 奥硝唑)治疗急性化脓性阑尾炎手术患者的临床资料(对照组),并同期回顾术后 80 例按照头孢曲松 + 奥硝唑抗感染治疗急性化脓性阑尾炎手术患者的临床资料(观察组)。针对两组不良反应发生率,治疗前、治疗 5d 后炎症因子水平,以及体温、住院时间进行统计。结果 手术当天,两组患者的体温水平比较无显著差异(P > 0.05)。术后 1d、3d、5d,观察组患者的体温水平均低于对照组,且住院时间短于对照组,差异均有显著性(P < 0.001)。治疗前,两组患者的 C 反应蛋白、肿瘤坏死因子α及白介素 -6 水平比较无显著差异(P > 0.05)。治疗后,两组患者炎症因子水平较治疗前均有所改善,且观察组患者的 C 反应蛋白、肿瘤坏死因子α及白介素 -6 水平均低于对照组,差异均有显著性(P < 0.01)。观察组术后不良反应发生率低于对照组(3.75% 比 12.50%),差异有显著性(P < 0.05)。结论 针对急性化脓性阑尾炎围手术期患者开展头孢曲松 + 奥硝唑抗感染治疗,可以降低患者术后不良反应发生风险,降低炎症因子水平,缩短患者住院时间。

关键词: 奥硝唑, 头孢曲松, 急性化脓性阑尾炎, 围手术期, 抗感染

Abstract:

Objective To observe the effect of using ceftriaxone combined with metronidazole for anti-infective treatment of patients with acute suppurative appendicitis during the perioperative period. Method A retrospective analysis was conducted on the clinical data of 80 patients with acute suppurative appendicitis who underwent routine postoperative anti-infective treatment (tranexamic acid+metronidazole) at Guilin Integrated Traditional Chinese and Western Medicine Hospital from May 2023 to May 2024 (control group). The clinical data of 80 patients with acute suppurative appendicitis who underwent postoperative anti-infective treatment with ceftriaxone+metronidazole (observation group) were also reviewed during the same period. Statistics were conducted on the incidence of adverse reactions, levels of inflammatory factors before and after 5d of treatment, body temperature, and length of hospital stay for two groups. Result On the day of surgery, there was no significant difference in body temperature levels between the two groups of patients (P > 0.05). On postoperative day 1, 3, and 5, the temperature levels of patients in the observation group were lower than those in the control group, and the hospitalization time was shorter than that in the control group, with significant differences (P < 0.001). Before treatment, there was no significant difference in the levels of C-reactive protein, tumor necrosis factor alpha, and interleukin-6 between the two groups of patients (P > 0.05). After treatment, the levels of inflammatory factors in both groups of patients improved compared to before treatment, and the levels of C-reactive protein, tumor necrosis factor alpha, and interleukin-6 in the observation group were significantly lower than those in the control group (P < 0.01). The incidence of postoperative adverse reactions in the observation group was lower than that in the control group (3.75% vs. 12.50%), and the difference was significant (P < 0.05). Conclusion The combination of ceftriaxone and metronidazole for anti-infective treatment of patients with acute suppurative appendicitis during the perioperative period can reduce the risk of postoperative adverse reactions, lower levels of inflammatory factors, and shorten hospital stay.

Key words: Metronidazole, Cefatriaxone, Acute suppurative appendicitis, Perioperative period, Anti-infection